Beneficial effects of estrogen replacement therapy in women over 70 years of ageAbstract Without Abstractdoi:10.1007/BF02500471Sunil J. WimalawansaSpringer-VerlagOsteoporosis International
BACKGROUND : The purpose of this study was to evaluate the cross-sectional and longitudinal association of oral estrogen replacement therapy (ERT) and cognitive function in an older, nondemented sample of women. METHODS : In a prospective cohort of 9651 white women aged 65 years and older ...
Osteoporosis, a clinical disorder that may lead to significant functional decline and decreased quality of life, affects many women over the age of 70. long-term experience with estrogen therapy has accumulated; however, traditionally its use has been reserved for younger postmenopausal women. When ...
Bone density is compromised in amenorrheic women despite return of menses: a 2-year study. Obstet Gynecol 1993; 81: 669–74 PubMed CAS Google Scholar Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001 Aug...
Moreover, although women with some risk factors for osteoporosis are more likely to use estrogen, the chief determinants of estrogen utilization are socioeconomic. 展开 关键词: Humans Osteoporosis Prevalence Multivariate Analysis Estrogen Replacement Therapy Postmenopause Age Distribution Alcohol Drinking ...
Women's Health VidyaGopinathMD, inMedical Clinics of North America, 2023 Estrogen therapy/hormone replacement therapy Estrogen withdrawal around menopause is associated with significantbone lossand the use of estrogen replacement therapy is FDA-approved for the prevention ofosteoporosis, though non-estrogen...
Estrogen replacement therapy has been associated with a reduction in cardiovascular events in postmenopausal women. One of the mechanisms responsible may b... DM Gilligan,AA Quyyumi,RO Cannon - 《Circulation》 被引量: 1331发表: 1994年 Effects of physiological levels of estrogen on coronary vasomotor...
These compounds are aimed to inhibit the production of E2 in postmenopausal women; thus, a current clinical usage of anastrozole, exemestane, and letrozole as they became useful in the management of patients with breast cancer lesions found to be E2 receptor positive. Aromatase inhibitors are also...
Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density It is desirable that young women with primary ovarian failure achieve normal peak bone mass to reduce the subsequent risk of osteoporosis, and that there a......
Materials and Methods Urinary constituents in 28 postmenopausal women on estrogen replacement therapy for more than 6 months were compared with those in 41 women who had never been exposed to estrogen after menopause. These 2 groups had a history of recurrent calcium oxalate urolithiasis. A group ...